150
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Pathophysiology and Management of Self-Poisoning with Beta-Blockers

, , &
Pages 531-551 | Published online: 25 Sep 2008

References

  • Henry JA, Cassidy SL. Membrane stabilizing activity: a major cause of fatal poisoning. Lancet 1986; 1: 1414–1417
  • Ellenhorn MJ, Barceloux DG. Class II drugs: Beta-blockers. Medical Toxicology. Diagnosis and Treatment of Human Poisoning, MJ Ellenhorn, DG Barceloux. Elsevier, New York 1988; 187–194
  • Bismuth C, Baud FJ, Muszynski J. Intoxication aiguë par les bétabloquants (80 cas). Conc Med 1989; 111: 1270–1272
  • Boakes AJ, Boeree BH. Suicidal attempts with beta-adrenoceptor blocking agents. Br Med J 1973; 4: 675
  • Prichard BN, Battersby LA, Cruickshank JM. Overdosage with beta-adrenergic blocking agents. Adverse Drug React Acute Poisoning Rev 1984; 3: 91–111
  • Elkharrat D, Bismuth C. Acute intoxication by beta-blocking agents: no mortality in 40 cases. Int J Clin Pharmacol Res 1982; 3: 207–210
  • Kulling P, Eleborg L, Persson H. Beta-adrenoceptor blocker intoxication. Epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction. Hum Toxicol 1983; 2: 175–181
  • Ellenhorn MJ, Barceloux DG. Beta-blocker. Medical Toxicology. Diagnosis and Treatment of Human Poisoning, MJ Ellenhorn, DG Barceloux. Elsevier, New York 1988; 187–194
  • Chen TW, Huang TP, Yang WC, Hong CY. Propranolol intoxication: three cases' experiences. Vet Hum Toxicol 1985; 27: 528–530
  • Langemeijer JJ, de Wildt DJ, de Groot G, Sangster B. Centrally induced respiratory arrest: a main cause of death in beta-adrenoceptor antagonist intoxication. Hum Toxicol 1986; 5: 65
  • Love JN, Tandy TK. Beta-adrenoceptor antagonist toxicity: a survey of glucagon availability. Ann Emerg Med 1993; 22: 267–268
  • Weinstein RS. Recognition and management of poisoning with beta-adrenergic blocking agents. Ann Emerg Med 1984; 13: 1123–1131
  • Gibson DG. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs 1974; 7: 8–38
  • Hoffman BB, Lefkowitz RJ. Adrenergic receptor antagonist. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Ed., AG Gilman, TW Rail, AS Niew, P Taylor. Pergamon Press, New York 1990; 229–243
  • Prichard B NC. Beta-adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol 1978; 5: 379–399
  • Lewis RV, McDevitt DG. Adverse reactions and interactions with beta-adrenoceptor blocking drugs. Med Toxicol 1986; 1: 343–361
  • Coltart DJ, Shand DG. Plasma propranolol levels in the quantitative assessment of beta-adrenergic blockade in man. Br Med J 1970; 3: 731–734
  • Khan A, Muscat-Baron JM. Fatal oxprenolol poisoning. Br Med J 1977; 1: 552
  • Berdeaux A, Giudicelli JF. Plasma levels and pharmacodynamic activity of beta-adrenergic inhibitors. Therapie 1985; 40: 383–386
  • Mylecharane EJ, Raper C. Further studies on the neuron blocking activity of some beta-adrenoceptor antagonists and guanethidine. J Pharm Pharmacol 1976; 23: 213–220
  • Shand DG, Nuckolls EM, Oates JA. Plasma propranolol levels in adults. Clin Pharmacol Ther 1970; 11: 112–120
  • Hong CY, Yang WC, Chiang BN. Importance of membrane stabilizing effect in massive overdose of propranolol: plasma level study in a fatal case. Hum Toxicol 1983; 3: 511–517
  • Frishman W, Jacob H, Eisenberg E, Rigner H. Clinical pharmacology of the new beta-adrenergic blocking agents. Part 8. Self-poisoning with beta-adrenoceptor blocking agents. Recognition and management. Am Heart J 1979; 98: 798–811
  • de Wildt D, Sangster B, Langemeijer J, de Groot G. Different toxicological profiles for various beta-blocking agents on cardiac function in isolated rat hearts. J Toxicol Clin Toxicol 1984; 22: 115–132
  • Moins N, Renoux M, Boucher M, Gachon P. Paradoxal pharmacologic effects observed with beta-blocker agents on cardiac cells in culture. In Vitro Cell Dev Biol 1991; 27A: 147–150
  • Rokutanda M, Araki S, Sakanashi M. A pharmacological investigation on a possible calcium antagonistic action of propranolol. Arch Int Pharmacodyn Ther 1983; 262: 99–108
  • Freslon JL. Couplage excitation-contraction des cellules musculaires: mécanismes et modulation pharmacologique. Pharmacologie Moléculaire, Y Landry, JP Gies. MEDSI/McGraw-Hill, Paris 1990; 265–294
  • Levitan IB. Modulation of ion channels in neurons and other cells. Ann Rev Neurosci 1988; 11: 119–136
  • Kamm KE, Stull JT. Activation of smooth muscle contraction: relation between myosin phosphorylation and stiffness. Science 1986; 232: 80–82
  • Whitsitt LS, Lucchesi BR. Effects of beta-receptor blockade and glucagon on the atrioventricular transmission system in the dog. Circ Res 1968; 23: 585–595
  • Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 1980; 49: 921–956
  • Kosinski EJ, Malindzak GS. Glucagon and isoproterenol in reversing propranolol toxicity. Arch Intern Med 1973; 132: 840–843
  • Femmer K, Poppe H, Schwela H, Oltmanns G, Fiekring H. Intoxicationen mit beta-receptoren blockern. Dt Gesundh Wesen 1983; 38: 259–263
  • Love JN, Leasure JA, Mundt DJ, Janz TG. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol Clin Toxicol 1992; 30: 399–412
  • Strubelt O. Evaluation of antidotes against the acute cardiovascular toxicity of propranolol. Toxicology 1984; 31: 261–270
  • Langemeijer J JM, de Wildt DJ, de Groot G. Respiratory arrest as main determinant of toxicity due to overdose with different beta-blockers in rats. Acta Pharmacol Toxicol 1985; 57: 352–356
  • Emorine LJ, Marullo S, Briend-Sutren MM, et al. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989; 245: 1118–1121
  • Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 1977; 77: 1–124
  • Best JD, Halter JB. Blood pressure and norepinephrine spillover during propranolol infusion in humans. Am J Physiol 1985; 248: R400–R406
  • Meyer PH. Les récepteurs présynaptiques, “modulateurs” de l'activité neuronale sympathique. Nouv Press Med 1979; 8: 1417–1420
  • Hesse B, Pedersen JT. Hypoglycemia after propranolol in children. Acta Med Scand 1973; 193: 551–552
  • Rosa RM, Silva P, Young JB, et al. Adrenergic modulation of extrarenal potassium disposal. N Eng J Med 1980; 302: 431–434
  • Halloran TJ, Phillips CE. Propranolol intoxication, a severe case responding to norepinephrine therapy. Arch Intern Med 1981; 141: 810–811
  • Lane AS, Woodward AC, Goldman MR. Massive propranolol overdose poorly responsive to pharmacologic therapy: Use of the intra-aortic balloon pump. Ann Emerg Med 1987; 16: 1381–1383
  • Chollet A, Bismuth C, Gaultier PJ. Intoxications aiguës par les bêta-bloquants A propos de 20 cas. Bull Med Legal 1979; 283–289
  • Agura ED, Wexler LF, Witzhurg RA. Massive propranolol overdose. Successful treatment with high dose isoproterenol and glucagon. Am J Med 1986; 180: 755–757
  • Langemeijer J, de Wildt D, de Groot G, Sangster B. Calcium interferes with the cardiodepressive effects of beta-blocker overdose in isolated rats. J Toxicol Clin Toxicol 1986; 24: 111–133
  • Sangster B, de Wildt D, van Dijk A. A case of acebutolol intoxication. J Toxicol Clin Toxicol 1983; 20: 69–77
  • Moller B HJ. Massive intoxication with metoprolol. Br Med J 1976; 1: 222
  • Illingworth RN. Glucagon for beta-blocker poisoning. Practitioner 1979; 223: 683–685
  • Peet M, Yates RA. Beta-blockers in the treatment of neurological and psychiatric disorders. J Clin Hosp Pharm 1981; 6: 151–171
  • Richards DA, Prichard B NC. Self-poisoning with beta-blockers. Br Med J 1978; 1: 1623–1624
  • Buiumsohn A, Eisenberg ES, Jacob H, et al. Seizures and intraventricular conduction defect in propranolol poisoning. Ann Intern Med 1979; 91: 860–862
  • Warwick GL, Boulton-Jones JM. Recurrent cardiovascular collapse due to surreptitious ingestion of propranolol. Br Med J 1989; 298: 294–295
  • Montagna M, Groppi A. Fatal sotalol poisoning. Arch Toxicol 1980; 43: 221–226
  • Stajic M, Granger RH, Beyer JC. Fatal metoprolol overdose. J Anal Toxicol 1984; 8: 228–230
  • Krapf R, Gertsch M. Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations. Br Med J Clin Res Ed 1985; 290: 1784–1785
  • Neuvonen PJ, Elonen E, Vuorenmaa T, Laakson M. Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication. Eur J Clin Pharmacol 1981; 20: 85–89
  • Tynan RF, Fisher MM, Ibels LS. Self-poisoning with propranolol. Med J Aust 1981; 24: 82–83
  • Ashouri OS. Metoprolol induced hyperkalemia in a diabetic with advanced renal failure. Arch Intern Med 1985; 145: 578
  • Freestone S, Thomas HM, Bhamra RK, Dyson EH. Severe atenolol poisoning: Treatment with prenalterol. Hum Toxicol 1986; 5: 343–345
  • Ward DE, Jones B. Glucagon and beta-blocker toxicity. Br Med J 1976; 2: 151
  • Levey GS, Epstein SE. Activation of adenylate cyclase by glucagon in cat and human heart. Circ Res 1969; 24: 151–156
  • Smith RC, Wilkinson J, Hull RL. Glucagon for propranolol overdose. JAMA 1985; 254: 2412
  • Parmley WW. The role of glucagon in cardiac therapy. N Engl J Med 1971; 285: 801–802
  • Jacobsen D, Helgeland A, Koss A. Treatment of beta-blocker poisoning. Lancet 1980; 1: 1031–1032
  • Goldfrank LR, Lewin NA, Howland MA, Kirstein RH, Hartnett L. Digitalis, beta blockers, calcium channel blockers, and clonidine. Goldfrank's Toxicologic Emergencies, 4th ed., LR Goldfrank, NE Flomenhaum, NA Lewin, et al. Appleton and Lange, Norwalk 1990; 270–287
  • Brimacombe JR, Scully M, Swainston R. Propranolol overdose—a dramatic response to calcium chloride. Med J Aust 1991; 155: 267–268
  • Bania TC, Sauter D, Hoffman RS. Management of hemodynamic compromise in the poisoned patient. Critical Care Toxicology, RS Hoffman, LR Goldfrank. Churchill Livingstone, New York 1991; 179–202
  • Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. Biochem Pharmacol 1991; 42: 735–743
  • Du Souich P, Caillé G, Larochelle P. Enhancement of nadolol elimination by activated charcoal and antibiotics. Clin Pharmacol Ther 1983; 33: 585–590
  • Kärkkäinen S, Neuvonen PJ. Effect of oral charcoal and urine pH on sotalol pharmacokinetics. Int J Clin Pharmacol Ther Toxicol 1984; 22: 441–446
  • Soni N, Baines D, Pearson IY. Cardiovascular collapse and propranolol overdose. Med J Aust 1983; 2: 629–630
  • Branch RA, Shand DG, Nies AS. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey. J Pharmacol Exp Ther 1973; 187: 581–587
  • Benowitz N, Rowland M, Forsyth R, Melmon KL. Circulatory influences on lidocaine disposition. Clin Res 1973; 21: 467
  • Lagerfelt J, Matell G. Attempted suicide with 5.1 g of propranolol, a case report. Acta Med Scand 1976; 199: 517–518
  • Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181–186
  • Vincent JL, Leon M, Berre J, Melot C, Kahn RJ. Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med 1992; 20: 1102–1106
  • Wetzel B, Hauel N. New cardiotonic agents—a promising approach for treatment of heart failure. Trends Pharmacol Sci 1988; 9: 166–170
  • Riou B, Barriot P, Rimailho M, Baud FJ. Treatment of severe chloroquine poisoning. N Eng J Med 1988; 318: 1–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.